Abstract:Background: Psychedelics have received renewed scientific attention in recent decades because of their potential to induce long-term changes in behaviour and cognition with potential therapeutic applications in various psychiatric indications. Aim: To provide a brief overview of the neurobiological action of classical serotonergic psychedelics, their impact on neural networks and implications for potential clinical applications. Method: We provide a non-exhaustive review of the current literature by subsequently and thematically outlining: 1. the empirical evidence concerning the action of psychedelics on the level of individual neuronal cells; 2.their effects on the level of neural networks; and 3. their influence on neuroplasticity and 4. different mechanistic hypotheses about the potential therapeutic effects of psychedelic substances. We illustrate this through key studies that provided important historical breakthroughs and show how these findings were integrated into the current theories. Results: Studies evidence the central role of 5-HT<span class="CharOverride-2" lang="en-US">2A</span> receptors for the subjective effects of psychedelics, as well as affinity for many other receptors. Through a complex cascade of downstream effects, psychedelic substances lead to dynamic changes in different neural circuits and increased neuroplasticity which potentially persists even after the subjective effects have subsided. Several theoretical concepts offer complementary explanations for the relationship between the effects at neurobiological and psychological levels. Conclusion: Although the underlying neurobiological mechanisms are not yet fully understood and methodological challenges remain, the current research offers valuable insights into how a single or a few administrations of a psychedelic substance could lead to symptom improvements that can last for weeks, months, or even longer, if used in a supportive setting and in combination with psychotherapy.

Preclinical models for evaluating psychedelics in the treatment of major depressive disorder

Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders

Neuroplasticity and Psychedelics: a comprehensive examination of classic and non-classic compounds in pre and clinical models

The mechanistic divide in psychedelic neuroscience: An unbridgeable gap?

Psychedelics and Other Psychoplastogens for Treating Mental Illness

New Paradigms of Old Psychedelics in Schizophrenia

Assessing the effects of methodological differences on outcomes in the use of psychedelics in the treatment of anxiety and depressive disorders: A systematic review and meta-analysis

Multimodal Neuroimaging of the Effect of Serotonergic Psychedelics on the Brain

Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine

Psychedelics and Neural Plasticity: Therapeutic Implications

Effective Use of Animal Models for Therapeutic Development in Psychiatric and Substance Use Disorders

Psychedelic research at a crossroads

The cyclical revival of psychedelics in psychiatric treatment

[Therapeutic applications of classical serotonergic psyche-delics: neurobiological mechanisms and neural networks]

Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice

A dual-receptor model of serotonergic psychedelics

Synergistic, Multi-level Understanding of Psychedelics: Three Systematic Reviews and Meta-analyses of Their Pharmacology, Neuroimaging and Phenomenology

Structural neural plasticity evoked by rapid-acting antidepressant interventions

Disentangling the acute subjective effects of classic psychedelics from their enduring therapeutic properties

Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression

Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern‐era clinical studies